Recruitment of specific leukocyte subpopulations at the site of inflammation requires a series of cell adhesion molecules (CAMs)-mediated interactions. The major CAMs, viz., intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin are expressed on endothelium in response to various cytokines. Caffeic acid (CA), a natural phenolic compound from herbs and other sources, has been shown to prevent cardiovascular diseases. We investigated the effect of CA on the expression of CAMs by human umbilical vein endothelial cells (HUVECs) stimulated with tumor necrosis factor (TNF-a a). Adhesion of monocytes to CAtreated HUVECs was evaluated by co-culture experiments using 2,7-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethylester (BCECF-AM) labeling of U937 cells. The expression of adhesion and chemoattractant molecules was evaluated by Western blot and reverse transcription-polymerase chain reaction (RT-PCR), respectively. CA significantly inhibited the TNF-a a-induced increase in U937 monocyte adhesion to HUVECs as well as decreased the protein and mRNA expression levels of CAMs on HUVECs. CA also inhibited the mRNA expression of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8). The involvement of nuclear factor (NF)-k kB in the transcriptional control of CAMs protein was assessed by degradation of inhibitory (I)k kB and nuclear translocation of NF-k kB using Western blotting and immunofluorescence staining. CA attenuated TNF-a ainduced Ik kB degradation and NF-k kB translocation from cytosol to the nucleus. In conclusion, TNF-a a-induced NF-k kB-DNA complex formation was inhibited by CA. CA reduced TNF-a a-induced endothelial adhesiveness to HUVECs by inhibiting transcription factor activation, and CAMs expression suggesting its potential role in atherosclerosis diseases.
Vascular inflammation is a pivotal event in the pathogenesis of many human diseases, including atherosclerosis. 1, 2) The inflammatory reaction is mediated by complex interactions between both circulating and resident leukocytes and vascular endothelium.
When in a normal condition, the endothelial cell surface of the lumen is a relatively non-adhesive and non-thrombogenic conduit for the cellular and macromolecular constituents of the blood. However, in the presence of certain diseases the adhesive interactions between the endothelial cells and constituents of the blood or extracellular matrix are changed due to the production of adhesion molecules resulting on their shedding onto endothelial and leukocyte surfaces. 3) These adhesion molecules are classified into two major classes: the Ig superfamily (IgSF; e.g., intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)) and the selectins (e.g., E-selectin). The activation of endothelial cells and resulting expression of adhesion molecules at sites of inflammation are of particular significance. Up-regulation of adhesion molecules on the surface of endothelial cells is prominent when they are exposed to pro-inflammatory molecules such as tumor necrosis factor (TNF)-a. 4) interleukin-8 (IL-8) and monocyte chemoattractant protein-1(MCP-1) production is present in human atherosclerotic plaques and participate in the development of atherosclerosis by recruiting monocytes into the subendothelial cell layer. 5, 6) Therefore, factors affecting the expression of endothelial adhesion molecules and chemokines are important in the regulation of the vascular inflammatory processes.
Induction of endothelial adhesion molecules by inflamma-tory cytokines, such as TNF-a, depends on activation of a transcription factor, specifically nuclear factor (NF)-kB. 7) NF-kB, in an inactive form that is often associated with its inhibitors; IkB proteins (IkBs) is located in the cytoplasm. In response to TNF-a stimulation, IkB is phosphorylated by IkB kinase (IKK), ubiquitinated, and proteolytically degraded; this allows the NF-kB to translocate into the nucleus. 8) Caffeic acid (CA) is a naturally occurring phenolic compound found in many fruits, vegetables, and herbs, including coffee in varying amounts depending on the plant. CA has been shown to confer a wide spectrum of positive biological effects such as antioxidant, anti-tumor, anti-metastatic, antiviral, anti-inflammatory and anti-rheumatic properties. 9, 10) CA may act as an antioxidant in endothelial cells, this role of CA would imply a directly link between it and vascular disease; specifically atherosclerosis. In parallel, it has been shown that CA inhibits angiotensin II-induced cell proliferation in vascular smooth muscle cells (VSMCs) from both SHR-SP and WKY. 11) Also, CA is known to have an antidiabetic effect in streptozotocin-induced diabetic rats. 12, 13) Although it has been reported that CA prevents hyperglycemia and atherogenesis and CA has antioxidant effect both in vivo and in vitro, there are no reports regarding the influence of CA on the expression of cell adhesion molecules and adhesion monocytes to endothelial cells. 9, 14, 15) The anti-inflammatory effect and molecular mechanism of CA in TNF-a-induced human umbilical vein endothelial cells (HUVECs) was investigated. Cell Cultures HUVECs were obtained from Cascade Biologics (Portland, Oregon) as cryo-preserved primary cultures, and grown in culture flasks (Costar) in endothelial cell growth medium M200 (Cascade Biologics) supplemented with 2% LSGS (low serum growth supplement; Cascade Biologics), according to Cascade Biologics' recommended protocol. The growth medium was changed every other day until cells reached confluence. Cells of passage 5 and 6 were grown in monolayers at 37°C in a humidified atmosphere of 5% CO 2 and 95% air, and used for experiments at Ͼ80% confluence. Twenty-four hours before experimentation, control medium was removed and replaced with LSGS-free medium containing 0.4% fetal bovine serum (FBS).
MATERIALS AND METHODS

Materials
Cell Enzyme-Linked Immunosorbent Assay (ELISA) ELISA was used to determine the level of ICAM-1, VCAM-1, and E-selectin expression on the surface, as previously described with minor modifications. 16) Briefly, HUVECs on the 96-well plates were pretreated with or without CA for 18 h, which was followed by a treatment with TNF-a for 6 h at 37°C. After the treatments, the cells were fixed by 1% paraformaldehyde and exposed to the mouse anti-human ICAM-1, VCAM-1, or E-selectin antibody at 1 : 1000 dilution in the PBS containing 1% skim milk for 2 h at room temperature. The cells were washed and incubated with a horseradish-peroxidase-conjugated secondary antibody. The expression of ICAM-1, VCAM-1, or E-selectin was quantified by adding a peroxidase substract solution and measuring the absorbance of each well at 490 nm using a Molecular device microplate reader (Menlo Park, CA, U.S.A.).
Cell Adhesion Assay HUVECs in 96-well plates were treated with CA for 18 h and/or TNF-a for 6 h. Cells of the human monocytic leukemic cell line U937 were labeled with 10 mM 2,7-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethylester (BCECF-AM, Acros, Geel, Belgium), in RPMI 1640 medium containing 10% FBS. In the co-culture system, the labeled U937 cells were seeded at a density of 4ϫ10 5 cells onto HUVECs and incubated for 30 min. The quantitative results were obtained using a fluoroscan ELISA plate reader (FLx800, Bio-Tek, U.S.A.) at 485 nm excitation and 535 nm emission wavelengths.
Western Blot Analysis HUVECs were pretreated with CA for 18 h and were then incubated with fresh growth medium containing TNF-a (10 ng/ml) for 6 h. For isolation of total cell extract, cells were lysed in PRO-PREP protein extract solution. The sample was centrifuged at 13000 rpm for 20 min at 4°C. Protein concentration was determined by the Bradford method. Thirty micrograms of protein were subjected to 10% SDS-polyacrylamide gel electrophoresis and transferred to PVDF membrane. The membranes were blocked with 5% nonfat milk in TBS-T [10 mM Tris-HCl (pH 7.6), 150 mM NaCl, and 0.05% Tween 20] for 2 h with the appropriate primary antibody at dilutions recommended by the supplier. Then the membrane was washed, and primary antibodies were detected with goat anti-rabbit IgG conjugated to horseradish peroxidase, and the bands were visualized with enhanced chemiluminescence (Amersham, Buckinghamshire, U.K.). Densitometric measurements of the band in western blot analysis were performed using digitalized scientific software program Chemi-doc (Bio-Rad, Hercules, CA, U.S.A.).
RNA Isolation and Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Total RNA was isolated from cultured endothelial cells using a commercially available kit. The yield and purity of the RNA were confirmed by measuring the ratio of the absorbances at 260 and 280 nm. In the first step, cDNA was prepared from 500 ng RNA by reverse transcription in a final volume of 20 ml in an Opticon MJ Research instrument. The samples were incubated at 37°C for 60 min and 94°C for 5 min. The following sets of primers were used in PCR amplification: VCAM-1: sense 5Ј-CAAATCCTTGATACTGCTCATC-3Ј, antisense 5Ј-TTGA-CTTCTTGCTCACAGC-3Ј; ICAM-1: sense 5Ј-GCTATG-CCTTGTCCTCTTG-3Ј, antisense 5Ј-ATACACACACACAC-ACACACGC-3Ј; E-selectin: sense 5Ј-TGCATGGAGG-GTTGTTAATGG-3Ј, antisense 5Ј-GGATGAAAGTGATTA-AATTGTGCATAG-3Ј; MCP-1: sense 5Ј-CAGCCAGATGCAA-TCAATG-C-3Ј, antisense 5Ј-GTGGTCCATGGAATCCTG-AA-3Ј; IL-8: sense 5Ј-AAACCACCGGAAGGAACCAT-3Ј, antisense 5Ј-CCTTCACACAGAGCTGCAGAAA-3Ј; GAPDH: sense 5Ј-CCACCCATGGCAAATTCCATG-3Ј, antisense 5Ј-TCTAGACGGCAGGTCAGGTCCACC-3Ј. Template cDNA and 50 nM primers were placed in PCR Pre-mix according to the manufacturer's specification (Bioneer, Korea). The amplification profile was as follows: an initial cycling at 94°C for 15 min followed by 45 cycles of 94°C, 20 s; 60°C, 20 s; 72°C, 30 s and a final extension of 72°C for 5 min. The PCR products were subjected to 1.2% agarose gel electrophoresis.
Real Time qRT-PCR Real-time quantitative RT-PCR analysis was carried out in a 48-well plate using the Opticon MJ Research instrument (Bio-rad Inc., U.S.A.) and optimized standard SYBR Green 2-step qRT-PCR kit protocol (Dy-NAmo TM , Finnzymes, Finland). The PCR was started at 95°C for 15 min (hot start) to activate the AmpliTaq polymerase, followed by a 45-cycle amplification (denaturation at 94°C for 20 s, annealing at 60°C for 30 s, extension at 72°C for 60 s, and plate reading at 60°C for 10 s). The temperature of PCR products was elevated from 65 to 95°C at a rate of 0.2°C/s, and the resulting data were analyzed by using the software provided by the manufacturer. The GAPDH housekeeping gene was used for normalization of MCP-1 and IL-8 amplifications.
MCP-1 Sandwich ELISA The concentration of MCP-1 released in the supernatant of TNF-a-stimulated endothelial cells was measured using a sandwich ELISA as described previously. 17 18) Cells were washed with PBS and collected by centrifugation. Cell pellets were homogenized in 200 ml of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, 2 mg/ml tosyl-lysylchloromethane, 5 mM NaF, 1 mM NaVO 4 , 10 mM Na 2 MO 4 ). After 15 min at 4°C, Nonidet P40 was added to reach 0.5% (v/v) concentration. The tubes were gently vortexed for 15 s and nuclei were collected by centrifugation at 8000 rpm for 15 min. The supernatants were stored at Ϫ80°C (cytosolic extracts) and the pellets were resuspended in 70 ml of buffer A supplemented with 20% (v/v) glycerol and 0.4 M KCl, and gently mixed for 30 min at 4°C. Nuclear proteins were obtained by centrifugation at 13000 rpm for 15 min and aliquots of the supernatant were stored at Ϫ80°C.
Electrophoretic Mobility Shift Assay Electrophoretic mobility shift assay (EMSA) for NF-kB was performed using a lightshift TM chemiluminescent EMSA kit (Pierce, Rockford, IL, U.S.A.) by following the manufacturer's protocol. To start with, DNA was biotin labeled using the Biotin 3Ј end labeling kit (Pierce, Rockford, IL, U.S.A.). Briefly, in a 50 ml reaction buffer, 5 pmol of double-stranded NF-kB oligonucleotide 5Ј-GATCTCAGAGGGGACTTTCGAGA-GA-3Ј; 3Ј-CTAGAGTCTCCCCTGAAAGGCTCTCT-5Ј, 10 ml of 5ϫterminal deoxynucleotidyl transferase (TdT) buffer, 5 ml of 5 mM biotin-N4-CTP, 10 U of diluted TdT, and 25 ml of ultrapure water were incubated at 37°C for 30 min. The reaction was stopped with 2.5 ml of 0.2 M EDTA. To extract labeled DNA, 50 ml of chloroform : isoamyl alcohol (24 : 1) was added to each tube and centrifuged briefly at 13000 g. The top aqueous phase containing the labeled DNA was removed and saved for binding reactions. Each binding reaction contained 1ϫbinding buffer (100 mM Tris, 500 mM KCl, 10 mM dithiothreitol, pH 7.5), 2.5% glycerol, 5 mM MgCl 2 , 50 ng/ml poly (dI-dC), 0.05% NP-40, 5 mg of nuclear extract and 20-50 fmol of biotin-end labeled target DNA. The content was incubated at room temperature for 20 min. To this reaction mixture, 5 ml of 5ϫloading buffer was added, subjected to gel electrophoresis on a native polyacrylamide gel and transferred to a nylon membrane. When the transfer was complete, DNA was cross-linked to the membrane at 120 mJ/cm 2 using a UV cross-linker equipped with 254 nm bulbs. The biotin-end labeled DNA was detected using streptavidin-HRP conjugate and a chemiluminescent substrate. The membrane was exposed to using digitalized scientific software program Quantity One ® (Silk Scientific Corporation, Orem, UT, U.S.A.).
Immunocytochemical Localization of NF-k kB p65 Subunit HUVECs were seeded on sterile slide cover slips in 6 well plates overnight and pretreated with CA before stimulated with TNF-a. Cells were fixed with 4% paraformaldehyde for 30 min at room temperature and made permeable with 0.1% Triton-100 in PBS for 30 min. Cells were proved with rabbit anti-NF-kB p65 (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) the primary antibody for 1 h at room temperature. Cells were washed three times with PBS and then incubated with FITC-conjugated goat anti-rabbit IgG as the secondary (Sigma, St. Louis, MO, U.S.A.) antibody was added. The slides were kept at 37°C for 45 min, and nuclear staining was performed with DAPI (Molecular Probe, Eugene, OR, U.S.A.). Cells were finally washed three times with PBS; cover slips were mounted with Dako Fluorescent mounting medium onto glass slides, and examined under a fluorescence microscope (Axiovision 4, Zeiss, Germany).
Statistical Analysis All the experiments were repeated at least three times. The results are expressed as the meanϮS.E.M. The data was analyzed by a Dunnett's test. A p-value Ͻ0.05 was considered significant.
RESULTS
CA Reduces TNF-a a-Induced Adhesion of Monocytes to HUVECs
To determine the effect of CA in the adhesion of U937 cells to endothelial cells, HUVECs were treated with different concentration of CA (5, 10, 25 mM). The percentage of cell adhesion was evaluated by the quantification of BCECF-AM staining method. CA treated HUVECs independently of the concentration, similar to control untreated cells, did not adhere to U937 cells. Adhesion of U937 cells to TNF-a stimulated HUVECs increased about 3.5-fold compared to control, and this adhesion was markedly decreased by treatment by CA (Fig. 1 ). An examination of the cytotoxicity of CA in the endothelial cells using an MTT assay indicated that CA had no adverse effect on the cell viability (Ͼ90% cell viability, was not shown). Therefore, the inhibition of monocyte adhesion to endothelial cells in the presence of CA was not the result of cytotoxicity.
Effects of CA on TNF-a a-Induced CAMs Expression Levels As the expression of cell adhesion molecules on endothelial cells is a prerequisite for adhesion of monocytes, the effect of CA on TNF-a-induced expression of ICAM-1, VCAM-1, and E-selectin was investigated. The results using cell-ELISA demonstrate that ICAM-1, VCAM-1, and E-selectin were expressed at low levels on unstimulated endothelial cells and there was more than two-fold increase in their expression upon stimulation with TNF-a. Pretreatment of endothelial cells with CA (25 mM) significantly inhibited TNF-a-induced VCAM-1, ICAM-1 and E-selectin expression levels (Fig. 2) . Western blotting of the cell lysate protein was carried out in order to confirm the effects of CA on the expression of the cell adhesion molecules in endothelial cells. Pretreatment of endothelial cells with CA also significantly inhibited the TNF-a-induced ICAM-1, VCAM-1 and E-selectin expression (Fig. 3A) . The observed changes in the levels of cell adhesion molecules might indicate a change in protein synthesis or degradation. The mRNA levels of the cell adhesion molecules were measured by RT-PCR in order to further clarify the mechanism responsible for the changes in the level of cell adhesion molecules. Pretreatment of endothelial cells with CA markedly decreased the ICAM-1, VCAM-1 and E-selectin mRNA levels (Fig. 3B) . This suggests that CA suppresses ICAM-1, VCAM-1 and E-selectin expression at the transcriptional level; this lowers the production of their protein and reduces the level of monocytes adhesion.
CA Inhibits TNF-a a-Induced MCP-1 and IL-8 mRNA Expressions
To determine if the inhibition of U937 cell adhesion by CA was associated with a possible down-regulation in chemoattractant molecule expression, HUVECs were cultured with CA or TNF-a. MCP-1 and IL-8 mRNA level was evaluated by RT-PCR. Figure 4A shows that TNF-a increased MCP-1 and IL-8 mRNA expression levels and pretreatment with CA decreased TNF-a-induced MCP-1 and IL-8 mRNA expression levels. Real time qRT-PCR results also showed that CA prevented TNF-a-induced MCP-1 and IL-8 mRNA expression levels (Fig. 4B ). In addition, pretreatment with CA also significantly prevented MCP-1 production from HUVECs stimulated with TNF-a ( Fig. 4C) .
CA Inhibits TNF-a a Induced NF-k kB Signaling Pathway This study examined whether or not CA could suppress NF-kB activation in the TNF-a in endothelial cells using EMSA 1374 Vol. 32, No. 8 and Western blotting. As shown in Fig. 5A , the TNF-a stimulated endothelial cells had a higher NF-kB-DNA-binding activity. However, CA distinctly inhibited NF-kB-DNAbinding activity in the nuclear extract from HUVECs treated with TNF-a. NF-kB p65 subunit expressed abundance in cytosol but less in the nucleus of unstimulated cells: however marked translocation of p65 NF-kB from the cytosol to the nucleus was observed in TNF-a-stimulated cells. In addition, pretreatment with CA inhibited the TNF-a-induced increase of nuclear NF-kB p65 and recovered of cytosolic IkB-a expression levels (Fig. 5B ). Furthermore, the regulatory effect of CA on TNF-a-induced nuclear translocation of the cytosolic NF-kB p65 subunit by immunocytochemistry ( Fig.  6 ). As expected was examined, CA treatment markedly suppressed the TNF-a-induced NF-kB p65 nuclear transloca-tion. These results indicate that CA may directly block the DNA-binding activity of NF-kB in the nucleus while affecting the degradation of IkB and nuclear translocation of NF-kB.
DISCUSSION
During the inflammation process, the activation of endothelium by proinflammatory cytokines is a crucial step, as it is directly responsible for the recruitment of the circulating leukocytes and their uptake into inflamed tissue. This process is self-maintaining and consequently, pharmacological agents that display a smothering effect on the activation of endothelium should be efficient as an anti-inflammatory. The interaction of monocytes with the arterial wall is mediated by chemokines such as MCP-1, which chemoattract circulating monocytes, adhesion molecules such as VCAM-1, ICAM-1, HUVECs were cultured on coverslips with culture medium only (control) and pretreated with CA and then stimulated by TNF-a. The cells were fixed and permeabilized and labeling was performed, first, with an anti-human NF-kB p65 antibody, and then, with a fluorescein isothiocyanate (FITC)-labeled secondary antibody. The nucleus was stained with 4Ј,6-diamidino-2-phenylindole (DAPI). The results were observed by implementing fluorescent microscopy, in which NF-kB p65 labeling appears (up row) and nuclear staining (down row) (A), (E) Control; (B), (F) TNF-a (10 ng/ml); (C), (G) cotreated with TNF-a and CA (10 mM); (D), (H) co-treated with TNF-a and CA (25 mM). and E-selectin expressed on the surface of endothelial cells. Adhesion molecule expression, monocyte adhesion and chemokine release are strongly induced in response to several inflammatory cytokines which are secreted during acute inflammation and the inflammatory process associated with the development of atherosclerosis. 19, 20) The stimulant effect of TNF-a-treatment on adhesion molecule expression, monocyte adhesion and chemokine release in HUVECs observed in the present study concurs with observations from other studies reported in literature. 21, 22) Some study showed that TNF-a increased only VCAM-1 expression but not other adhesion molecules. 23) Whereas, recent study showed TNF-a-induced only ICAM, VCAM-1, and E-selectin expressions. 24, 25) We suspected that this discrepancy may be due to the difference of experimental design including species, incubation time, vascular tissues, etc.
This study found that CA inhibits TNF-a-induced ICAM-1, VCAM-1, and E-selectin expression in HUVECs. The mRNA expression of all three adhesion molecules tested, in this report, including ICAM-1, VCAM-1, and E-selectin were also down-regulated by CA treatment. These adhesion molecules are well known to be important for the attachment of inflammatory cells to arterial wall. 26) Previous reports also showed that the functional blocking of these adhesion molecules suppressed U937 cell adhesion to HUVECs. 27) Therefore, it can be assumed that the inhibition of U937 cell adhesion to HUVECs by CA is mediated by its inhibitory effect on the adhesion molecule expression in HUVECs. Together, the inhibitory effect of CA on U937 cell adhesion and the adhesion molecule expression presented in this report provide a new mechanism responsible for the anti-inflammatory activity of CA. The recruitment of mononuclear cells to the endothelium is regulated by chemoattracting molecules secreted by activated vascular endothelial cells. 28) Specific chemotactic cytokines have been classified and subdivided into the CXC and the CC family; IL-8, a mediator of acute inflammatory reactions, is a key member of the former, and MCP-1, a mediator in chronic inflammation, of the latter. 29) During monocyte : HUVECs interaction there is an increased production of IL-8 and MCP-1, but very little information exists on the possible role of CA in this cellular interaction. 30) The aim of this work was to determine if CA inhibits the adhesion of mononuclear cells to TNF-a-induced HUVECs, and whether regulation of chemotactic molecules is involved. The data collected from this study demonstrates that CA inhibited TNF-a induced mRNA expression level of MCP-1 and IL-8. In addition, pretreatment with CA inhibited mRNA of these chemokines in HUVECs. The changes of MCP-1 in the medium reflected the mRNA levels. These results suggest that CA may be useful in preventing the vascular inflammatory process.
Activated nuclear factor kB (NF-kB) has been identified in situ in human atherosclerotic plaques but is absent or present in only very small amounts in vessels devoid of atherosclerosis. 31) A number of genes implicated in the development of atherosclerosis are regulated by NF-kB. Leukocyte adhesion molecules, such as VCAM-1, ICAM-1, and Eselectin, as well as the chemokines, MCP-1, and IL-8, recruit circulating mononuclear leukocytes to the arterial intima. 32, 33) There is a high correlation between NF-kB activation and the levels of adhesion molecules in atherosclerotic lesions in vivo. 34) Recently, many groups including this laboratory have identified a number of small molecules from natural sources, as well as several plant extracts that block nuclear accumulation of NF-kB and abrogate TNF-a induced expression of ICAM-1, VCAM-1, and E-selectin on endothelial cells. 35, 36) The efficacy of several identified compounds have also been tested using in vivo models. [37] [38] [39] Inhibition of these molecules by various small molecules has been shown to downregulate the expression of cell adhesion molecules and is effective in controlling various inflammatory diseases. 40) This study, confirmed that TNF-a induced NF-kB-DNA complex formation was attenuated in the presence of CA. The analysis indicated that CA decreased NF-kB p65 translocation from cytosol to nucleus. However, it was surprising that cytosolic NF-kB p65 expression was also decreased in the presence of CA. As described earlier, the dissociation of NF-kB from IkB requires phosphorylation IkB, which results in rapid and ubiquitous degradation of IkB. In this study, TNF-a induced IkB degradation was attenuated by CA. Therefore, it is possible that CA interferes with NF-kB and IkB protein expression by affecting their synthesis and/or increasing their degradation. It would be interesting to identify such additional factors affected by CA in future studies.
It was shown that cytokine-activated endothelial expression of the cell adhesion molecules and monocytes adhesions to endothelial cells are inhibited by natural antioxidants via the suppression of NF-kB activation. [41] [42] [43] In addition, several types of natural antioxidants, including catechins, flavonoids, and related polyphenolic compounds, have been shown to inhibit adhesion molecule expression and the adhesion of monocytes to endothelial cells. 44, 45) Previous studies have shown that CA is effective in protecting U937 against tert-butyl hydroperoxide-induced oxidative damage both in vivo and in vitro. 46) Therefore, the inhibitory effect of CA on the TNF-a-induced activation of NF-kB might be due to its antioxidant properties. This finding, in conjunction with a report showing that CA prevents hyperglycemia and atherogenesis, suggests that CA can play an important role in preventing atherosclerosis. 14, 15) In summary, this study has demonstrated that CA blocks the early atherogenic process involving endothelial expression of inducible adhesion molecules. CA blocked monocytes adhesion on the TNF-a-activated endothelium and the activation of CAMs expression. The selective inhibition of CAMs expression by CA was at least in part mediated via the affecting NF-kB signaling pathway. This effect of CA might have implications for strategies preventing and attenuating inflammatory diseases. The CA-responsive mechanisms appear to be dependent of NF-kB-sensitive transcriptional regulatory mechanisms and may argue for transcriptional mechanisms as the major target of the anti-atherogenic action of CA.
